No Data
Repare Therapeutics: A Strong Buy on Robust Financials and Promising Clinical Pipeline
Repare Therapeutics Inc. Just Reported A Surprise Profit And Analysts Updated Their Estimates
It's been a good week for Repare Therapeutics Inc. (NASDAQ:RPTX) shareholders, because the company has just released its latest first-quarter results, and the shares gained 8.7% to US$3.64. Reve
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial results and issued second-quarter revenue guidance below estim
Repare Therapeutics Shares Rise 17% After 1Q Earnings, Revenue Beats
By Chris Wack Repare Therapeutics shares were up 17% to $3.85 after the company reported first-quarter earnings that beat analysts' expectations. The company reported quarterly earnings of $13 milli
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Repare Therapeutics Shares Are Trading Higher Following Better-than-expected Q1 Financial Results.
Small Cap Bid Up Following Key Q1 Earnings Beat